Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

9.58
Delayed Data
As of 2:54pm ET
 +0.07 / +0.74%
Today’s Change
7.57
Today|||52-Week Range
14.40
-29.61%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close9.51
Today’s open9.35
Day’s range9.35 - 9.59
Volume67,638
Average volume (3 months)208,879
Market cap$403.1M
Dividend yield--
Data as of 2:54pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+2.11%
Earnings growth (this year)-19.66%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+11.64%
P/E ratioNM
Price/Sales18.39
Price/Book5.10

Competitors

 Today’s
change
Today’s
% change
NEONeogenomics Inc+0.11+1.75%
NVTAInvitae Corp+0.39+3.99%
CTICCTi Biopharma Corp-0.02-1.30%
RDNTRadNet Inc+0.06+1.01%
Data as of 2:56pm ET, 09/04/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$30.6M
Annual profit (last year)-$38.3M
Net profit margin-125.07%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Chief Financial Officer
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts

Partner Offers